Cargando…

The Sphingosine-1-Phosphate (S1P) Lysophospholipid Receptor S1P(3) Regulates MAdCAM-1(+) Endothelial Cells in Splenic Marginal Sinus Organization

Marginal zones (MZs) are microdomains in the spleen that contain various types of immune cells, including MZ B cells, MOMA1(+) metallophilic macrophages, and mucosal addressin cell adhesion molecule 1 (MAdCAM-1)(+) endothelial cells. MAdCAM-1(+) and MOMA1(+) cells line the sinus, that separates MZs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Girkontaite, Irute, Sakk, Vadim, Wagner, Martin, Borggrefe, Tilman, Tedford, Kerry, Chun, Jerold, Fischer, Klaus-Dieter
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2004
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2211946/ https://www.ncbi.nlm.nih.gov/pubmed/15583019 http://dx.doi.org/10.1084/jem.20041483

Ejemplares similares

Development of Mucosal PNAd(+) and MAdCAM-1(+) Venules during Disease Course in Ulcerative Colitis
por: Roosenboom, Britt, et al.
Publicado: (2020)

Bile acids regulate MAdCAM-1 expression to link the gut microbiota to cancer immunosurveillance
por: Fidelle, Marine, et al.
Publicado: (2023)

The Force-Dependent Mechanism of an Integrin α4β7–MAdCAM-1 Interaction
por: Su, Youmin, et al.
Publicado: (2023)

TNF-α induced endothelial MAdCAM-1 expression is regulated by exogenous, not endogenous nitric oxide
por: Oshima, Tadayuki, et al.
Publicado: (2001)

MAdCAM-1-Mediated Intestinal Lymphocyte Homing Is Critical for the Development of Active Experimental Autoimmune Encephalomyelitis
por: Kuhbandner, Kristina, et al.
Publicado: (2019)

Involvement of oxidative stress and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in inflammatory bowel disease
por: Tanida, Satoshi, et al.
Publicado: (2011)

Melatonin reduces TNF-a induced expression of MAdCAM-1 via inhibition of NF-kB.
por: Sasaki, Makoto, et al.
Publicado: (2002)

Bile Acids Modulate Colonic MAdCAM-1 Expression in a Murine Model of Combined Cholestasis and Colitis
por: Gao, Rachel Y., et al.
Publicado: (2020)

Circulating MAdCAM-1 and ITGB7 in Patients with Plaque Psoriasis and Eruptive Lichen Planus—Preliminary Data
por: Baran, Anna, et al.
Publicado: (2021)

Anti-MAdCAM-1-Conjugated Nanocarriers Delivering Quantum Dots Enable Specific Imaging of Inflammatory Bowel Disease
por: Truffi, Marta, et al.
Publicado: (2020)

Vedolizumab blocks α4β7 integrin-mediated T cell adhesion to MAdCAM-1 in microscopic colitis
por: Besendorf, Laura, et al.
Publicado: (2022)

Anti-MAdCAM-1 antibody (PF-00547659) for active refractory Crohn’s disease in Japanese and Korean patients: the OPERA study
por: Saruta, Masayuki, et al.
Publicado: (2020)

MAdCAM costimulation through Integrin-α(4)β(7) promotes HIV replication
por: Nawaz, Fatima, et al.
Publicado: (2018)

α4β7 integrin-dependent adhesion of T cells to MAdCAM-1 is blocked by vedolizumab in patients with chronic refractory pouchitis
por: Melde, Michaela, et al.
Publicado: (2021)

MAdCAM-1/α4β7 Integrin-Mediated Lymphocyte/Endothelium Interactions Exacerbate Acute Immune-Mediated Hepatitis in Mice
por: Schippers, Angela, et al.
Publicado: (2020)

Force-Regulated Calcium Signaling of Lymphoid Cell RPMI 8226 Mediated by Integrin α(4)β(7)/MAdCAM-1 in Flow
por: Sun, Dongshan, et al.
Publicado: (2023)

A Small Molecule, Which Competes with MAdCAM-1, Activates Integrin α(4)β(7) and Fails to Prevent Mucosal Transmission of SHIV-SF162P3
por: Arrode-Brusés, Géraldine, et al.
Publicado: (2016)

Transfection of IL-10 expression vectors into endothelial cultures attenuates α4β7-dependent lymphocyte adhesion mediated by MAdCAM-1
por: Sasaki, Makoto, et al.
Publicado: (2003)

Correction: A Small Molecule, Which Competes with MAdCAM-1, Activates Integrin α(4)β(7) and Fails to Prevent Mucosal Transmission of SHIV-SF162P3
por: Arrode-Brusés, Géraldine, et al.
Publicado: (2016)

Phase II evaluation of anti-MAdCAM antibody PF-00547659 in the treatment of Crohn’s disease: report of the OPERA study
por: Sandborn, William J, et al.
Publicado: (2018)

Differential Effects of the Absence of Nkx2-3 and MAdCAM-1 on the Distribution of Intestinal Type 3 Innate Lymphoid Cells and Postnatal SILT Formation in Mice
por: Vojkovics, Dóra, et al.
Publicado: (2019)

Baseline levels of dynamic CD4(+) T cell adhesion to MAdCAM-1 correlate with clinical response to vedolizumab treatment in ulcerative colitis: a cohort study
por: Allner, Clarissa, et al.
Publicado: (2020)

Antibody secreting cells are critically dependent on integrin α4β7/MAdCAM-1 for intestinal recruitment and control of the microbiota during chronic colitis
por: Tyler, Christopher J., et al.
Publicado: (2021)

Inflammatory cytokines induce MAdCAM-1 in murine hepatic endothelial cells and mediate alpha-4 beta-7 integrin dependent lymphocyte endothelial adhesion In Vitro
por: Ando, Tomoaki, et al.
Publicado: (2007)

Long-term Safety and Efficacy of the Anti-MAdCAM-1 Monoclonal Antibody Ontamalimab [SHP647] for the Treatment of Ulcerative Colitis: The Open-label Study TURANDOT II
por: Reinisch, Walter, et al.
Publicado: (2021)

MAdCAM-1 costimulation in the presence of retinoic acid and TGF-β promotes HIV infection and differentiation of CD4(+) T cells into CCR5(+) T(RM)-like cells
por: Vimonpatranon, Sinmanus, et al.
Publicado: (2023)

Anti-MAdCAM Antibody Increases ß7+ T Cells and CCR9 Gene Expression in the Peripheral Blood of Patients With Crohn’s Disease
por: Hassan-Zahraee, Mina, et al.
Publicado: (2018)

Population Pharmacokinetics and Pharmacodynamics of Ontamalimab (SHP647), a Fully Human Monoclonal Antibody Against Mucosal Addressin Cell Adhesion Molecule‐1 (MAdCAM‐1), in Patients With Ulcerative Colitis or Crohn's Disease
por: Wang, Yi, et al.
Publicado: (2020)

Sphingosine kinase 1/sphingosine-1-phosphate (S1P)/S1P receptor axis is involved in ovarian cancer angiogenesis
por: Dai, Lan, et al.
Publicado: (2017)

The opposing forces of shear flow and sphingosine-1-phosphate control marginal zone B cell shuttling
por: Tedford, Kerry, et al.
Publicado: (2017)

Sphingosine 1-Phosphate Receptor 5 (S1P(5)) Knockout Ameliorates Adenine-Induced Nephropathy
por: Eckes, Timon, et al.
Publicado: (2022)

The nuclear export factor Xpo1p targets Mad1p to kinetochores in yeast
por: Scott, Robert J., et al.
Publicado: (2009)

Synthesis of Lysophospholipids
por: D’Arrigo, Paola, et al.
Publicado: (2010)

Triple Negative Breast Cancer Depends on Sphingosine Kinase 1 (SphK1)/Sphingosine-1-Phosphate (S1P)/Sphingosine 1-Phosphate Receptor 3 (S1PR3)/Notch Signaling for Metastasis
por: Wang, Shushu, et al.
Publicado: (2018)

Role of sphingosine 1-phosphate (S1P) in sepsis-associated intestinal injury
por: Sun, Gehui, et al.
Publicado: (2023)

Association of Sphingosine‐1‐phosphate (S1P)/S1P Receptor‐1 Pathway with Cell Proliferation and Survival in Canine Hemangiosarcoma
por: Rodriguez, A.M., et al.
Publicado: (2015)

Association of Sphingosine‐1‐phosphate (S1P)/S1P Receptor‐1 Pathway with Cell Proliferation and Survival in Canine Hemangiosarcoma
Publicado: (2018)

Sphingosine 1-phosphate receptor 2 (S1P(2)) attenuates reactive oxygen species formation and inhibits cell death: implications for otoprotective therapy
por: Herr, Deron R., et al.
Publicado: (2016)

Sphingosine 1-Phosphate (S1P)/ S1P Receptor Signaling and Mechanotransduction: Implications for Intrinsic Tissue Repair/Regeneration
por: Sassoli, Chiara, et al.
Publicado: (2019)

Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway Modulators, from Current Insights to Future Perspectives
por: Bravo, Gary Álvarez, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p7nr8141ni63h46hl1cl1o8n0g